These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 37629648)

  • 1. Safety and Feasibility of Transarterial Bleomycin-Lipiodol Embolization in Patients with Giant Hepatic Hemangiomas.
    Kacała A; Dorochowicz M; Patrzałek D; Janczak D; Guziński M
    Medicina (Kaunas); 2023 Jul; 59(8):. PubMed ID: 37629648
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transarterial Bleomycin-Lipiodol Embolization (B/LE) for Symptomatic Giant Hepatic Hemangioma.
    Akhlaghpoor S; Torkian P; Golzarian J
    Cardiovasc Intervent Radiol; 2018 Nov; 41(11):1674-1682. PubMed ID: 29922860
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transarterial Bleomycin-Lipiodol Chemoembolization for the Treatment of Giant Hepatic Hemangiomas: An Assessment of Effectiveness.
    Kacała A; Dorochowicz M; Korbecki A; Sobański M; Puła M; Patrzałek D; Janczak D; Guziński M
    Cancers (Basel); 2024 Jan; 16(2):. PubMed ID: 38254869
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transarterial embolization with bleomycin-lipiodol emulsion: a successful minimal invasive approach for giant liver hemangioma.
    Kurniawan J; Teressa M; Budiman RA; Matondang SBRE
    Clin J Gastroenterol; 2024 Jun; 17(3):511-514. PubMed ID: 38526803
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effectiveness of Transarterial Embolization in Treatment of Symptomatic Hepatic Hemangiomas: Systematic Review and Meta-analysis.
    Torkian P; Li J; Kaufman JA; Jahangiri Y
    Cardiovasc Intervent Radiol; 2021 Jan; 44(1):80-91. PubMed ID: 32808203
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transcatheter Arterial Embolization with Bleomycin-Lipiodol of Hepatic Hemangiomas: Safety, Efficacy and Predictors of Response.
    Zhao D; Xie L; Makamure J; Liu Z; Zhang L; Li Q; Zhang X; Zhao Y; Zheng C; Shi L; Liang B
    Cardiovasc Intervent Radiol; 2024 Jul; 47(7):931-942. PubMed ID: 38509337
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-Term Outcomes of Transarterial Chemoembolization of Giant Liver Hemangiomas with Lipiodol-Bleomycin Emulsion.
    Küsbeci M; Elek A; Oztürk E; Bozkaya H; Cınar C; Parıldar M; Oran I
    Cardiovasc Intervent Radiol; 2024 Nov; 47(11):1506-1514. PubMed ID: 39406873
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Superselective Transarterial Chemoembolization as an Alternative to Surgery in Symptomatic/Enlarging Liver Hemangiomas.
    Özden İ; Poyanlı A; Önal Y; Demir AA; Hoş G; Acunaş B
    World J Surg; 2017 Nov; 41(11):2796-2803. PubMed ID: 28634838
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transarterial Chemoembolization of Giant Liver Haemangioma: A Multi-center Study with 836 Cases.
    Li Y; Jia Y; Li S; Wang W; Wang Z; Wang Y; Liu B; Wang W; Chang H; Li Z
    Cell Biochem Biophys; 2015 Nov; 73(2):469-472. PubMed ID: 27352340
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transcatheter arterial chemoembolization in patients with hepatocellular carcinoma and coexisting hepatic cavernous hemangioma.
    Chen RC; Lii JM; Chen WT; Tu HY; Chiang LC
    Eur Radiol; 2006 Jun; 16(6):1346-50. PubMed ID: 16331460
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Unusual outcome following transarterial chemoembolization of giant hepatic hemangioma using bleomycin and lipiodol.
    Mikos E; Szmygin M; Kidziński R; Lesiuk P; Czeczelewski M; Pyra K
    Pol Arch Intern Med; 2024 Sep; 134(9):. PubMed ID: 39007767
    [No Abstract]   [Full Text] [Related]  

  • 12. Feasibility and Safety of Repeated Transarterial Chemoembolization Using Miriplatin-Lipiodol Suspension for Hepatocellular Carcinoma.
    Matsumoto T; Ichikawa H; Imai J; Hayashi T; Tomita K; Mine T; Kojima S; Watanabe N; Hasebe T
    Anticancer Res; 2017 Jun; 37(6):3183-3187. PubMed ID: 28551662
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cerebral lipiodol embolism after transarterial chemoembolization for hepatic carcinoma: a case report.
    Jia ZZ; Tian F; Jiang GM
    World J Gastroenterol; 2012 Aug; 18(30):4069-70. PubMed ID: 22912560
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transarterial injection of (131)I-lipiodol, compared with chemoembolization, in the treatment of unresectable hepatocellular cancer.
    Marelli L; Shusang V; Buscombe JR; Cholongitas E; Stigliano R; Davies N; Tibballs J; Patch D; Meyer T; Burroughs AK
    J Nucl Med; 2009 Jun; 50(6):871-7. PubMed ID: 19443599
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatic arterial damage after transarterial chemoembolization for the treatment of hepatocellular carcinoma: comparison of drug-eluting bead and conventional chemoembolization in a retrospective controlled study.
    Lee S; Kim KM; Lee SJ; Lee KH; Lee DY; Kim MD; Kim DY; Kim SU; Won JY
    Acta Radiol; 2017 Feb; 58(2):131-139. PubMed ID: 27217418
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy and safety analysis of dexamethasone-lipiodol emulsion in prevention of post-embolization syndrome after TACE: a retrospective analysis.
    Lu H; Zheng C; Liang B; Xiong B
    BMC Gastroenterol; 2021 Jun; 21(1):256. PubMed ID: 34116638
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Percutaneous Sclerotherapy with Bleomycin and Ethiodized Oil: A Promising Treatment in Symptomatic Giant Liver Hemangioma.
    Ayoobi Yazdi N; Mehrabinejad MM; Dashti H; Pourghorban R; Nassiri Toosi M; Rokni Yazdi H
    Radiology; 2021 Nov; 301(2):464-471. PubMed ID: 34402664
    [TBL] [Abstract][Full Text] [Related]  

  • 18. C-arm Lipiodol CT in transcatheter arterial chemoembolization for small hepatocellular carcinoma.
    Li JJ; Zheng JS; Cui SC; Cui XW; Hu CX; Fang D; Ye LC
    World J Gastroenterol; 2015 Mar; 21(10):3035-40. PubMed ID: 25780303
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cerebral Lipiodol Embolism in Hepatocellular Carcinoma Patients Treated with Transarterial Embolization/Chemoembolization.
    Chu HJ; Lee CW; Yeh SJ; Tsai LK; Tang SC; Jeng JS
    PLoS One; 2015; 10(6):e0129367. PubMed ID: 26107693
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tumor vascularity and lipiodol deposition as early radiological markers for predicting risk of disease progression in patients with unresectable hepatocellular carcinoma after transarterial chemoembolization.
    Chen CS; Li FK; Guo CY; Xiao JC; Hu HT; Cheng HT; Zheng L; Zong DW; Ma JL; Jiang L; Li HL
    Oncotarget; 2016 Feb; 7(6):7241-52. PubMed ID: 26769845
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.